Srivastava, A.; Renna, H.A.; Johnson, M.; Sheehan, K.; Ahmed, S.; Palaia, T.; Pinkhasov, A.; Gomolin, I.H.; Wisniewski, T.; De Leon, J.;
et al. Nilotinib as a Prospective Treatment for Alzheimer’s Disease: Effect on Proteins Involved in Neurodegeneration and Neuronal Homeostasis. Life 2024, 14, 1241.
https://doi.org/10.3390/life14101241
AMA Style
Srivastava A, Renna HA, Johnson M, Sheehan K, Ahmed S, Palaia T, Pinkhasov A, Gomolin IH, Wisniewski T, De Leon J,
et al. Nilotinib as a Prospective Treatment for Alzheimer’s Disease: Effect on Proteins Involved in Neurodegeneration and Neuronal Homeostasis. Life. 2024; 14(10):1241.
https://doi.org/10.3390/life14101241
Chicago/Turabian Style
Srivastava, Ankita, Heather A. Renna, Maryann Johnson, Katie Sheehan, Saba Ahmed, Thomas Palaia, Aaron Pinkhasov, Irving H. Gomolin, Thomas Wisniewski, Joshua De Leon,
and et al. 2024. "Nilotinib as a Prospective Treatment for Alzheimer’s Disease: Effect on Proteins Involved in Neurodegeneration and Neuronal Homeostasis" Life 14, no. 10: 1241.
https://doi.org/10.3390/life14101241
APA Style
Srivastava, A., Renna, H. A., Johnson, M., Sheehan, K., Ahmed, S., Palaia, T., Pinkhasov, A., Gomolin, I. H., Wisniewski, T., De Leon, J., & Reiss, A. B.
(2024). Nilotinib as a Prospective Treatment for Alzheimer’s Disease: Effect on Proteins Involved in Neurodegeneration and Neuronal Homeostasis. Life, 14(10), 1241.
https://doi.org/10.3390/life14101241
